Literature DB >> 1706070

Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.

N Abraham1, M C Miceli, J R Parnes, A Veillette.   

Abstract

Lymphocyte-specific tyrosine protein kinase p56lck is physically associated with CD4 and CD8 T-cell surface molecules, suggesting that it may transduce CD4/CD8-triggered tyrosine phosphorylation signals during antigen stimulation. Indeed, antibody-mediated aggregation of CD4 (to mimic interaction with its ligand, major histocompatibility complex (MHC) class II molecules), rapidly elevates the kinase activity of p56lck and is associated with marked changes in tyrosine protein phosphorylation. Genetic analyses suggest that the interaction of CD4/CD8 with p56lck results in a positive signal during antigen-induced T-cell activation. To evaluate directly the role of p56lck in T-cell activation, we introduced a constitutively activated form of Lck protein (tyrosine 505 to phenylalanine 505 mutant); in a CD4-negative, MHC-class II restricted mouse T-cell hybridoma. We report here that, as for transfection of CD4, expression of the Lck mutant enhanced T-lymphocyte responsiveness. This finding provides direct evidence that p56lck can positively regulate T-cell functions and that it mediates at least some of the effects of CD4 and CD8 on T-cell activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1706070     DOI: 10.1038/350062a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  70 in total

1.  SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.

Authors:  B Wang; S Lemay; S Tsai; A Veillette
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling.

Authors:  S Lemay; D Davidson; S Latour; A Veillette
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 3.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling.

Authors:  Y Yamanashi; Y Fukui; B Wongsasant; Y Kinoshita; Y Ichimori; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

Review 5.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

6.  Lck-dependent Fyn activation requires C terminus-dependent targeting of kinase-active Lck to lipid rafts.

Authors:  Dominik Filipp; Behrouz Moemeni; Alessandra Ferzoco; Kirishanthy Kathirkamathamby; Jenny Zhang; Ondrej Ballek; Dominique Davidson; André Veillette; Michael Julius
Journal:  J Biol Chem       Date:  2008-07-27       Impact factor: 5.157

7.  Feedback control of T-cell receptor activation.

Authors:  Cliburn Chan; Jaroslav Stark; Andrew J T George
Journal:  Proc Biol Sci       Date:  2004-05-07       Impact factor: 5.349

8.  Constitutive tyrosine phosphorylation of the T-cell receptor (TCR) zeta subunit: regulation of TCR-associated protein tyrosine kinase activity by TCR zeta.

Authors:  N S van Oers; W Tao; J D Watts; P Johnson; R Aebersold; H S Teh
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4.

Authors:  L Briant; V Robert-Hebmann; C Acquaviva; A Pelchen-Matthews; M Marsh; C Devaux
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Ntk: a Csk-related protein-tyrosine kinase expressed in brain and T lymphocytes.

Authors:  L M Chow; C Jarvis; Q Hu; S H Nye; F G Gervais; A Veillette; L A Matis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.